Welcome to Add-Aspirin

This website is designed to provide information about the Add-Aspirin Trial, both for people taking part in the trial (participants) and collaborators. Please use the menus at the top of the screen to find out more about the trial.

Add-Aspirin is a large randomised clinical trial, which is taking place in the UK and India. It will recruit 11,000 participants to help find out whether regular aspirin use after treatment for an early stage cancer can prevent the cancer from coming back and preventing deaths.

Congratulations to our top 5 recruiting centres:

  1. University Hospitals Coventry & Warwickshire
  2. Worcestershire Royal Hospital
  3. Tata Memorial Hospital, Mumbai
  4. Royal Marsden Hospitals
  5. Bristol Haematology & Oncology Centre

*FOR GENERAL AND CLINICAL QUERIES, PLEASE CHECK OUR FAQs*

News

Add-Aspirin hits 5000 participants registered!

We are thrilled to have more than 5000 patients registered on Add-Aspirin which reflects the hard work and dedication of staff across the UK and India. Over 2300 participants have now been registered in the breast cohort, and more than 3900 participants have been randomised overall.

Read more

Quick Links

Register a participant

To RANDOMISE a participant please call +44 (0)20 7670 4777

Unblind a participant

Newsletter

Breast

We aim to recruit 3100 individuals who have had surgery to remove an early stage breast cancer.

CURRENT STATUS:
OPEN 

Detailed eligibility criteria available here 

Top recruiters: UHCW, Worcestershire Royal Hospital, Tata Memorial Hospital Mumbai, Royal Marsden Hospitals, 

PARTICIPANTS REGISTERED: 2363
PARTICIPANTS RANDOMISED: 1906

Colon/Rectum

We aim to to recruit 2600 individuals who have had surgery to remove an early stage bowel cancer. 

CURRENT STATUS:
OPEN 

Detailed eligibility criteria available here 

Top recruiters: Bristol Haematology & Oncology Centre, St James 's University Hospital, Darlington Memorial Hospital

PARTICIPANTS REGISTERED: 1355
PARTICIPANTS RANDOMISED: 1072

Gastro

We aim to recruit 2100 individuals who have had surgery or a combination of chemotherapy and radiotherapy to treat a cancer of the stomach or oesophagus (food pipe).

CURRENT STATUS:
OPEN 

Detailed eligibility criteria available here

Top recruiters:
Tata Memorial Hospital Mumbai, The Christie, St James's University Hospital, 

PARTICIPANTS REGISTERED: 248
PARTICIPANTS RANDOMISED: 183

Prostate

We aim to recruit 2120 individuals who have had surgery or radiotherapy to treat an early stage prostate cancer.

CURRENT STATUS:
OPEN 

Detailed eligibility criteria available here

Top recruiters: UCHW,  University Hospital of Wales, Bristol Haematology & Oncology Centre

PARTICIPANTS REGISTERED: 1087
PARTICIPANTS RANDOMISED: 866

the trial is being jointly funded by